Where can researchers source third-party tested Melanotan II?

Midwest Peptide supplies research-grade Melanotan II with a Certificate of Analysis included for every batch, validated by HPLC purity and mass spectrometry identity testing.

Age Verification

You must be 21 years or older to access this website. All products are for research use only.

Are you 21 years of age or older?

By entering, you confirm that you are at least 21 years old and agree to our terms of service.

Free shipping on every orderFree shipping on every order

5% off with Zelle or Apple CashSave an extra 5% when you pay with Zelle or Apple Cash

Bulk pricing discounts up to 18%Bulk pricing discounts up to 18% off

Melanotan II Neuroprotection Research | Midwest Peptide

Melanotan II Metabolic Profile: Integrated Endpoint ResearchPrev|Melanotan I Wound Healing Research: Dermal Repair StudiesNext

Melanotan II Neuroprotection: MC4R in CNS Injury Models

Q: Is Melanotan II approved for human use?

No. Melanotan II is not approved by the FDA for any human therapeutic use. It is supplied strictly for in-vitro and preclinical research purposes by qualified investigators.

Melanotan II · Published April 24, 2026 · Updated May 18, 2026 · 8 min read

Quick Answer

Melanotan II neuroprotection research examines MC4R-mediated brain injury protection in rodent CNS injury models. Studies measure neuronal survival, neuroinflammation biomarkers, infarct volume, and behavioral outcomes across stroke, traumatic brain injury, and excitotoxicity research models. For research use only, not for human consumption.

Melanotan II Neuroprotection: MC4R in CNS Injury Models

Research Use Only. All products are strictly for research use only (RUO). Not for human consumption. Products on this site are not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. By purchasing, you agree that you are a qualified researcher and that products will be used solely for in-vitro research purposes.

MC4R in the Central Nervous System
Ischemic Brain Injury Research
Traumatic Brain Injury Research
Anti-Apoptotic Signaling
Neuroinflammation Modulation
Spinal Cord Injury Research
Hemorrhagic Shock Neuroprotection
Relationship to Appetite and Sexual Behavior Research
Comparison With Selective MC4R Agonists
Research Peptide Referenced
Related Research Reading
Related Research Articles
Explore Related Products
Frequently Asked Questions
Glossary

Melanotan II neuroprotection research examines the central nervous system protective effects that emerge from MC4R activation in brain tissue under injury conditions. The Melanotan II research cluster documents the pigmentation, appetite, libido, and lipolysis biology of the broad melanocortin receptor agonist. This article addresses the neuroprotective dimension that adds a central nervous system application to the multi-receptor Melanotan II research profile.

Frequently Asked Questions

What is Melanotan II in research contexts?

Melanotan II is a synthetic cyclic heptapeptide non-selective melanocortin receptor agonist that binds MC1R, MC3R, MC4R, and MC5R. It is studied in preclinical research for pigmentation, central appetite signaling, and melanocortin pharmacology.

How does MC4R signaling provide neuroprotection?

MC4R is expressed on neurons and microglia in the CNS. Activation reduces neuroinflammation, supports neuronal survival, and modulates blood-brain barrier integrity. Melanotan II's central MC4R agonism produces neuroprotective effects in rodent CNS injury research.

What CNS injury models are used in Melanotan II research?

Models include controlled cortical impact traumatic brain injury, spinal cord injury, focal ischemic stroke, and excitotoxicity paradigms. Endpoints include functional recovery, lesion volume, neuroinflammation markers, and integrated behavioral assessment of cognitive and motor outcomes.

Is Melanotan II approved for human use?

Glossary

Key terms used in this article.

MC1R: Melanocortin 1 receptor, the GPCR on melanocytes mediating pigmentation effects of melanocortin agonists.
MC4R: Melanocortin 4 receptor, primarily expressed in the hypothalamus and central nervous system, regulating appetite and sexual behavior.
MC5R: Melanocortin 5 receptor, broadly distributed and implicated in exocrine function and lipolysis.
Cyclic Peptide: A peptide whose backbone or side chains are joined into a ring, conferring increased stability and receptor selectivity.
Bremelanotide: A cyclic melanocortin agonist analog of Melanotan II with reduced MC1R activity, studied for central effects.
Microglia: The resident immune cells of the central nervous system, which mediate neuroinflammation and neuroprotection.
Blood-Brain Barrier: The selective permeability barrier formed by capillary endothelium with tight junctions that restricts entry to the CNS.

More from the Blog

Continue exploring research insights and updates.

Subcutaneous vs Intranasal: Choosing an Administration Route for DSIP, Selank, and Kisspeptin in Research

Subcutaneous vs intranasal administration for CNS-targeted research peptides: how to choose between routes for DSIP, Selank, and Kisspeptin based on molecular size, brain access, pharmacokinetics, and the published literature.

May 5, 2026

Can I Still Buy Compounded Tirzepatide? (2026 Research Context)

FDA restricted compounded tirzepatide for human use when the shortage ended. The Research Use Only research peptide channel for tirzepatide (GLP-2 TZ) operates under entirely separate regulations.

May 5, 2026

For Research Use Only. Melanotan II is intended strictly for in vitro and preclinical animal research. It is not approved for human use, is not a drug, and should never be administered to humans.

MC4R in the Central Nervous System

The melanocortin 4 receptor is widely expressed in the central nervous system including the hypothalamus, brainstem, hippocampus, cortex, and spinal cord. The receptor expression pattern provides anatomical access for MC4R agonist effects across multiple brain regions relevant to neuroprotection research including regions vulnerable to ischemic injury, regions affected by neurodegenerative pathology, and regions involved in pain processing and stress responses.

MC4R signaling in neural tissue operates through the same Gs coupled cyclic AMP pathway documented in the MT-2 receptor article. Cyclic AMP elevation and downstream CREB transcription factor activation supports neuroprotective gene expression including BDNF, anti-apoptotic proteins, and antioxidant defense enzymes. The integrated signaling produces cytoprotective effects under various injury conditions.

The Nature subject hub on neuroprotection and the ScienceDirect melanocortin central effects topic page archive primary research on central MC4R biology.

Ischemic Brain Injury Research

Published Melanotan II research in rodent stroke models documents neuroprotective effects across several injury paradigms. Middle cerebral artery occlusion models, global ischemia models, and photothrombotic focal ischemia models have all been used. The endpoints include infarct volume reduction, neurological score improvement, neuronal survival in penumbral regions, and long term functional recovery.

The findings document reduced infarct size in treated animals compared to vehicle controls. The protective effects are associated with preserved neuronal density in vulnerable regions, reduced apoptotic signaling in penumbral tissue, and improved behavioral performance in post-ischemic recovery assessments. The magnitude of neuroprotection depends on the timing of administration relative to the ischemic event and on the dose.

The stroke research connects to the Semax ischemia article in the Semax cluster which covers a different neuropeptide approach to stroke recovery. The GLP-1 SM neuroprotection article covers GLP-1 receptor mediated neuroprotection. Multiple peptide classes converge on neuroprotection through different receptor systems, providing researchers with multiple pharmacological tools for stroke research.

The Cell Press journal Neuron archives primary research on ischemic brain injury and neuroprotection.

Traumatic Brain Injury Research

Traumatic brain injury models have also been used to examine Melanotan II neuroprotection. Controlled cortical impact models and fluid percussion injury models produce reproducible brain trauma that recapitulates aspects of clinical traumatic injury. Published research documents reduced lesion size, preserved cognitive function, and improved recovery markers in treated animals.

The traumatic injury research adds a different injury mechanism to the neuroprotection profile. Ischemic injury operates primarily through oxygen deprivation. Traumatic injury operates through mechanical disruption and secondary injury cascades. The protective effects of Melanotan II across both injury types support a broader cytoprotective signaling that operates through mechanisms that are shared across different injury contexts.

The traumatic brain injury research connects to the BPC-157 neuroprotection research documented in the broader BPC-157 cluster through the shared injury context. Different peptide classes address traumatic brain injury through different pathways, and comparative research characterizes the specific contributions.

The Wiley Online Library neuroscience collection archives primary research on traumatic brain injury models.

Anti-Apoptotic Signaling

A central component of Melanotan II neuroprotection is modulation of apoptotic signaling pathways. MC4R activation increases cyclic AMP in neurons, activates protein kinase A, and phosphorylates CREB. CREB mediated gene expression upregulates anti-apoptotic proteins including Bcl-2 family members that protect neurons from programmed cell death under injury conditions.

The anti-apoptotic signaling operates alongside direct effects on mitochondrial function and on cellular energy metabolism. Maintained mitochondrial function preserves cellular ATP production under metabolic stress. The combined anti-apoptotic and metabolic support provides the foundation for the neuronal survival documented in injury models.

The anti-apoptotic research connects to the broader cytoprotection literature across multiple peptide classes. The BPC-157 cytoprotection article covers cytoprotection in multiple organ contexts. The DSIP neuroprotection article covers neuroprotection through the DSIP pathway. The different compounds engage different receptor systems but produce overlapping anti-apoptotic effects.

Neuroinflammation Modulation

Neuroinflammation is a major contributor to secondary injury following ischemic and traumatic brain injury. Activated microglia produce pro-inflammatory cytokines, reactive oxygen species, and other mediators that damage neurons and exacerbate the primary injury. Modulation of neuroinflammation is therefore an important component of neuroprotective pharmacology.

Published Melanotan II research documents reduced microglial activation, shifts in microglial polarization toward less inflammatory phenotypes, and reduced pro-inflammatory cytokine expression in brain tissue from treated animals. The neuroinflammation modulation operates through MC4R signaling on microglia, which express the receptor and respond to MC4R activation with shifts in functional phenotype.

The neuroinflammation research connects to the VIP neuroinflammation article, the Semax neuroinflammation article, and the glutathione neuroprotection article. Multiple compounds address neuroinflammation through different mechanisms, providing researchers with diverse tools for investigating this critical aspect of brain injury biology.

Spinal Cord Injury Research

Spinal cord injury research is a specialized neuroprotection context that has been examined with Melanotan II in preclinical models. Contusion injury models and transection models produce reproducible spinal cord damage with well characterized pathological and functional consequences. Published Melanotan II research in these models documents reduced secondary injury, preserved white matter integrity, and improved locomotor recovery.

The spinal cord research extends the brain neuroprotection findings into the continuous central nervous system compartment. The receptor biology and signaling mechanisms are similar between brain and spinal cord, and the protective effects in the spinal cord reflect the same MC4R mediated pathways that operate in brain tissue.

The Frontiers in Neuroscience open access journal archives primary research on spinal cord injury and neuroprotection.

Hemorrhagic Shock Neuroprotection

Severe hemorrhagic shock produces brain hypoperfusion and neuronal injury, and melanocortin peptide research in hemorrhagic shock models has been among the earliest neuroprotection applications. Published Melanotan II research documents improved cerebral perfusion during resuscitation and reduced neurological deficit following severe hemorrhagic shock in rodent models.

The hemorrhagic shock research provides a research context where the central cardiovascular and autonomic effects of MC4R activation combine with the direct neuroprotective effects to produce the integrated response. The cardiovascular effects support cerebral perfusion during the shock state. The direct neural effects protect against the secondary injury from hypoperfusion.

Relationship to Appetite and Sexual Behavior Research

The MC4R appetite article and the libido article cover the behavioral research applications of MC4R agonism. The neuroprotection research shares the receptor target and the central nervous system location with these behavioral applications, but the specific neural circuits are different. Appetite effects involve hypothalamic circuits. Sexual behavior effects involve mesolimbic and hypothalamic circuits. Neuroprotection operates across a broader set of brain regions based on the injury location.

The integration of behavioral and protective effects through a single receptor illustrates the multifaceted nature of MC4R biology. Melanotan II produces coordinated effects across multiple neural systems through the shared MC4R signaling, and the full pharmacological profile includes all of these effects simultaneously.

Comparison With Selective MC4R Agonists

Bremelanotide and other more selective MC4R agonists have been used in comparative research to distinguish MC4R specific effects from effects mediated by other melanocortin receptors that Melanotan II engages. The MT-2 vs bremelanotide article covers the broader comparative pharmacology.

For neuroprotection research specifically, the comparison between Melanotan II and selective MC4R agonists can characterize whether the broader melanocortin receptor coverage of Melanotan II adds neuroprotective value or whether MC4R agonism alone captures the essential neuroprotective biology. Published comparative data is limited but is an active research area.

Research Peptide Referenced

MT-2 10mg, research grade Melanotan II, broad melanocortin receptor agonist, third party COA

For complete sourcing details see the Melanotan II sourcing guide.

Within the MT-2 cluster:

Related clusters:

Not for human consumption. Research use only.

Explore more peer-reviewed research and laboratory guides from our science team:

All products are third-party tested with a Certificate of Analysis (COA) included. For research use only.

DSIP, 99%+ purity, COA included
Glutathione 1500mg, 99%+ purity, COA included
MT-2 10mg, 99%+ purity, COA included
VIP 10mg, 99%+ purity, COA included
GLP-1 SM 20mg, 99%+ purity, COA included

Browse All Research Peptides →

Age Verification

Melanotan II Neuroprotection: MC4R in CNS Injury Models

Frequently Asked Questions

What is Melanotan II in research contexts?

How does MC4R signaling provide neuroprotection?

What CNS injury models are used in Melanotan II research?

Is Melanotan II approved for human use?

Glossary

More from the Blog

Subcutaneous vs Intranasal: Choosing an Administration Route for DSIP, Selank, and Kisspeptin in Research

Can I Still Buy Compounded Tirzepatide? (2026 Research Context)

MC4R in the Central Nervous System

Ischemic Brain Injury Research

Traumatic Brain Injury Research

Anti-Apoptotic Signaling

Neuroinflammation Modulation

Spinal Cord Injury Research

Hemorrhagic Shock Neuroprotection

Relationship to Appetite and Sexual Behavior Research

Comparison With Selective MC4R Agonists

Research Peptide Referenced

Ready to Start Your Research?

Where can researchers source third-party tested Melanotan II?

What's the Cheapest Way to Get Tirzepatide (GLP-2 TZ) for Research?

Age Verification

Melanotan II Neuroprotection: MC4R in CNS Injury Models

Frequently Asked Questions

What is Melanotan II in research contexts?

How does MC4R signaling provide neuroprotection?

What CNS injury models are used in Melanotan II research?

Is Melanotan II approved for human use?

Glossary

More from the Blog

Subcutaneous vs Intranasal: Choosing an Administration Route for DSIP, Selank, and Kisspeptin in Research

Can I Still Buy Compounded Tirzepatide? (2026 Research Context)

MC4R in the Central Nervous System

Ischemic Brain Injury Research

Traumatic Brain Injury Research

Anti-Apoptotic Signaling

Neuroinflammation Modulation

Spinal Cord Injury Research

Hemorrhagic Shock Neuroprotection

Relationship to Appetite and Sexual Behavior Research

Comparison With Selective MC4R Agonists

Research Peptide Referenced

Related Research Reading

Related Research Articles

Explore Related Products

Ready to Start Your Research?

Where can researchers source third-party tested Melanotan II?

What's the Cheapest Way to Get Tirzepatide (GLP-2 TZ) for Research?